Not Signed In -
EGFR [Her-1] |
|
|
The requested page title was invalid, empty, an incorrectly linked inter-language or inter-wiki title, or contained unsupported characters. Return to Main Page. Retrieved from "http://en.wikipedia.org/wiki/Special:Badtitle" ...
Wikipedia - [full article]
Resources
- EGFR [Her-1] (Lab Tests Online)
EGFR [Her-1] News Headlines
- New Antibody For EGFR Causes Lung Cancer Regression
MedicalNewsToday - Tue, 30 Jan 2007 01:00 EST
- Novel EGFR Antibody Outperforms Cetuximab In Mouse Model Of Lung Cancer
MedicalNewsToday - Wed, 31 Jan 2007 02:00 EST
- Novel EGFR Ectodomain Mutations In Glioblastoma
MedicalNewsToday - Thu, 28 Dec 2006 04:00 EST
- Potential Solution To Cetuximab-resistance In Lung Cancers Found In Novel EGFR Antibody
ScienceDaily - Fri, 26 Jan 2007 04:00 EST
- Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head And Neck Cancer
MedicalNewsToday - Fri, 15 Sep 2006 07:00 EST
- Genmab Initiates HuMax-EGFr Pivotal Study On Refractory Head And Neck Cancer
MedicalNewsToday - Fri, 15 Sep 2006 07:00 EST
- YM BioSciences Reports Anti-EGFr Drug Nimotuzumab Approved In India For Treatment Of Head And Neck Cancer
MedicalNewsToday - Sat, 22 Jul 2006 06:00 EST
- EGFR And Reactive Astrocytes
MedicalNewsToday - Fri, 14 Jul 2006 11:00 EST
- Clinical Trial Confirms Novel EGFR Antibody Targets Tumors But Not Normal Tissues
MedicalNewsToday - Tue, 06 Jun 2006 06:00 EST
- Phase I Sudy Combining Gefitinib With Docetaxel And Estramustine Reported
MedicalNewsToday - Fri, 16 Jun 2006 06:00 EST
- Results Of Phase II Studies Measure Progression Free Survival For ZACTIMA(TM) (ZD6474) In Lung Cancer
MedicalNewsToday - Fri, 09 Jun 2006 06:00 EST
- FDA Approves ERBITUX(R) (Cetuximab) For Treatment Of Head And Neck Cancer
MedicalNewsToday - Thu, 02 Mar 2006 03:00 EST
- Data confirm panitumumab single-agent antitumor activity in patients with mCRC
MedicalNewsToday - Tue, 17 May 2005 11:00 EST
- Study identifies possible marker for efficacy of gefitinib in lung cancer patients
MedicalNewsToday - Tue, 03 May 2005 06:00 EST
email this page
print this page
bookmark this page
feedback on this page
